CJC-1295 No DAC
Growth Hormone & SecretagoguesA tetra-substituted analogue of growth hormone releasing hormone (1-29) without the Drug Affinity Complex. Used in GHRH receptor research.
Standalone GHRH analogue that stimulates the pituitary to release growth hormone in a natural pulsatile pattern. Without the DAC modification, it offers a shorter half-life and a more physiological GH pulse, supporting recovery, lean tissue development, and metabolic balance while preserving endogenous feedback mechanisms.
Also known asModified GRF 1-29, Mod GRF, CJC1295 without DAC, CJC-1295 (NO DAC)
Available formats
- Form
- Lyophilized powder
- Storage
- Store lyophilized at 2–8°C, protected from light. Ships at ambient temperature.
- CAS Number
- Available on request
- Molecular Formula
- Available on request
- Molecular Weight
- Available on request
- Purity
- Available on request
- Sequence
- Available on request
For laboratory research use only. Not for human or veterinary consumption. Not a drug, food, cosmetic, or medical device. Not for diagnostic or therapeutic use. Sold to qualified research and institutional buyers only.
Related products
Ipamorelin
A selective pentapeptide growth hormone secretagogue and ghrelin receptor agonist. Used as a reference standard in endocrine and receptor-binding research.
CJC-1295 DAC
A GHRH (1-29) analogue conjugated with a Drug Affinity Complex for extended plasma half-life. Used in peptide pharmacokinetics research.
Tesamorelin
A synthetic analogue of growth hormone releasing factor (1-44). Used as a reference compound in metabolic endocrinology research.
HGH Fragment 176-191
A synthetic C-terminal fragment corresponding to residues 176-191 of the human growth hormone sequence. Used in lipid metabolism research models.